filmov
tv
Novavax's Gregory Glenn, MD, talks about company's coronavirus vaccine candidate (Live 2/24)

Показать описание
Gregory M. Glenn, MD, is the president of research and development at vaccine maker Novavax, whose COVID-19 vaccine candidate is the first to demonstrate clinical efficacy against the original coronavirus and both of the variants first identified in the U.K. and South Africa. If approved, the Novavax vaccine will be the first protein-based vaccine available, and the company is already working on an updated version of the vaccine to test against the new variants. Washington Post national health-care policy reporter Paige Winfield Cunningham interviews Glenn on Wednesday, Feb. 24 at 12:00pm ET.
Follow us:
#WashingtonPostLive #Novavax
Follow us:
#WashingtonPostLive #Novavax
Full Frame: Coronavirus Vaccine with Dr. Gregory Glenn, Novavax
Novavax Could Deliver 100M Covid-19 Vaccine Doses By End of Year, Says R&D Head
Potential 4th Covid vaccine as Novavax phase three results show it's safe
Novavax COVID-19 vaccine trial opens at UT Health San Antonio and University Health
Novavax Vaccine in 'Good Shape' for Approval Filing: CEO
Novavax Sending 200 Million Vaccines to EU
Novavax Enters Finals Stage Of COVID-19 Trials
U.S Study of Novavax COVID Vaccine Continues With Two More Shots for Volunteers
Novavax vaccine trial prepares for FDA approval | Reporter researches 4th vaccine option
Novavax CEO discusses earnings, COVID-19 vaccine trial progress, and FDA approval
Novavax: Vaccine has 89.3% efficacy, works vs. new variants
Novavax Phase 3 COVID-19 Vaccine Trial | GITVC
Participant perspectives: Novavax COVID-19 phase 3 vaccine trial
Novavax trial shows its Covid-19 and influenza vaccine as ‘well-tolerated’
Novavax COVID-19 vaccine trial underway for kids 12-17, participants needed
Atrium Health Opens Novavax Vaccine Clinical Trial for COVID-19
Novavax progresses to testing possible coronavirus vaccine in humans
S. Korea secures more Pfizer and Novavax vaccines
Hogan Visits Novavax
Novavax seeks children 12-17 for paid COVID-19 vaccine clinical trial
US biotech firm Novavax begins human trial of COVID-19 vaccine in Australia
COVID 19 Vaccine Comparison | Which Vaccine is the Best?
Novavax CEO: Biotech Bounce Back | Mad Money | CNBC
Coronavirus: Scientists in the US race to find a vaccine
Комментарии